Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 compounds have become one of the most evidence-backed weight loss tools available today. Clinical trials show that medications like semaglutide and tirzepatide help patients lose substantial amounts of weight by reducing appetite and improving blood sugar control. PlexusDx delivers these compounds from licensed compounding pharmacies, with personalized dosing and genetic insights to optimize your results.
How GLP-1 Compounds Work for Weight Loss
GLP-1 receptor agonists mimic a natural hormone your gut produces when you eat. This hormone signals your brain that you're full, slowing stomach emptying and reducing hunger cues throughout the day. By activating GLP-1 receptors in areas of the brain that control appetite, these compounds help you feel satisfied with smaller portions and fewer cravings for high-calorie foods.
Beyond appetite suppression, GLP-1 compounds improve how your body processes glucose and regulates metabolism. This dual action—reduced hunger plus metabolic support—makes them effective for sustained weight loss rather than temporary calorie restriction. Many patients report feeling fuller longer and having less obsessive thoughts about food within the first few weeks of treatment.
Clinical Evidence Supporting GLP-1 Weight Loss Results
The STEP trials, which followed over 4,500 patients taking semaglutide, found that participants lost an average of 15% of their starting body weight over 68 weeks—significantly more than those on diet and exercise alone. Patients receiving the highest dose lost up to 22% of their body weight, with many maintaining those losses for years after starting treatment. These results are among the strongest seen in any weight loss intervention study to date.
Tirzepatide, a dual GIP and GLP-1 receptor agonist, has shown even more dramatic results in clinical trials, with some patients losing 22% of their body weight within 72 weeks. The combination of two receptor pathways appears to amplify appetite reduction and improve metabolic control. PlexusDx offers both semaglutide and tirzepatide formulations to match your individual response and goals.
Personalization Through Genetic Testing and Dosing
Not everyone responds identically to GLP-1 compounds due to genetic variations in appetite-regulating pathways. PlexusDx's Precision Peptide Genetic Test examines key variants in genes like GLP1R, GIPR, FTO, and MC4R—identifying whether your biology favors stronger response to GLP-1 alone, dual-pathway therapy, or microdose protocols. This genetic roadmap helps your provider select the right compound and starting dose from day one.
Your dose may need to go up as your body adapts and your provider titrates your medication safely. Your price won't. PlexusDx charges a flat monthly rate regardless of dose level, so your investment remains predictable as your treatment progresses. Starting semaglutide injection at $149/month gives you access to a proven, personalized weight loss program without surprise costs tied to dose increases.
Why Choose PlexusDx for Compounded GLP-1 Therapy
PlexusDx sources all medications from licensed 503A compounding pharmacies, which operate under strict pharmaceutical standards and state oversight. Unlike mass-manufactured options, compounded medications can be tailored to your needs while maintaining the same active pharmaceutical ingredients proven in clinical trials. This approach allows for flexibility in dosing, formulation (injection or oral), and combination therapy without membership fees or insurance requirements.
PlexusDx serves all 50 states and makes treatment accessible through HSA and FSA accounts, reducing out-of-pocket costs for eligible patients. The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 150+ genetic insights, empowering you and your provider to make data-driven decisions about your ongoing care. Whether you start with semaglutide injection at $149/month or explore combination therapy, PlexusDx builds a weight loss plan around your genetics and budget.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I realistically lose on GLP-1 compounds?
Clinical trial data shows most patients lose 15-22% of their starting body weight over 12-18 months, though results vary based on genetics, diet, exercise, and individual metabolism. PlexusDx's Precision Peptide Genetic Test can help identify which compound and dose pathway may work best for your genetic profile, potentially optimizing your outcome.
What is the difference between semaglutide and tirzepatide?
Semaglutide activates the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors, offering dual-pathway appetite suppression. Tirzepatide typically produces stronger weight loss results in trials, but semaglutide remains highly effective and may be ideal if you prefer a single-pathway approach. PlexusDx offers both as injection or oral formulations to match your preference.
How much does PlexusDx GLP-1 treatment cost per month?
PlexusDx compounded semaglutide injection starts at $149/month flat, regardless of your dose level. Tirzepatide injection starts at $249/month, and oral formulations begin at $249-$279/month depending on the compound. All pricing is HSA/FSA eligible, and no membership or insurance is required—your dose may increase, but your monthly price remains stable.
Are there side effects or safety concerns with GLP-1 compounds?
Common side effects include mild nausea, constipation, and reduced appetite during the first 1-4 weeks as your body adjusts. These effects typically diminish as your system adapts. Serious side effects are rare when medications are prescribed and monitored properly through a licensed provider, and GLP-1 compounds have an established safety profile from millions of doses worldwide.
Does the Precision Peptide Genetic Test predict which GLP-1 will work best for me?
Yes. The test analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes, plus 10 additional pathways affecting hunger, satiety, and metabolic response. These insights help your PlexusDx provider recommend whether semaglutide, tirzepatide, or dual-pathway therapy aligns with your genetic predispositions, increasing the likelihood of optimal weight loss and tolerability.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Semaglutide Dosing Explained: How Many Doses in Your Vial?
How Much Does the Ozempic Shot Cost?